These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 8547633
1. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Hong Y, Martin JF, Vainchenker W, Erusalimsky JD. Blood; 1996 Jan 01; 87(1):123-31. PubMed ID: 8547633 [Abstract] [Full Text] [Related]
8. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells. Chou CC, Yung BY, Hsu CY. Life Sci; 2007 May 08; 80(22):2051-9. PubMed ID: 17448503 [Abstract] [Full Text] [Related]
11. Protein kinase C in erythroid and megakaryocytic differentiation: possible role in lineage determination. Lumelsky NL, Schwartz BS. Biochim Biophys Acta; 1997 Aug 21; 1358(1):79-92. PubMed ID: 9296525 [Abstract] [Full Text] [Related]
12. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages. Murate T, Saga S, Hotta T, Asano H, Ito T, Kato K, Tsushita K, Kinoshita T, Ichikawa A, Yoshida S. Exp Cell Res; 1993 Sep 21; 208(1):35-43. PubMed ID: 8359227 [Abstract] [Full Text] [Related]
13. Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein. Testa U, Grignani F, Hassan HJ, Rogaia D, Masciulli R, Gelmetti V, Guerriero R, Macioce G, Liberatore C, Barberi T, Mariani G, Pelicci PG, Peschle C. Leukemia; 1998 Apr 21; 12(4):563-70. PubMed ID: 9557615 [Abstract] [Full Text] [Related]
14. Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells. Chou CC, Hsu CY. Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan 21; 379(1):1-9. PubMed ID: 18758751 [Abstract] [Full Text] [Related]
15. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Bakić M, Ozawa K, Uemura N, Nishikawa M, Tojo A, Takahashi K, Tani K, Zaike Y, Ikebuchi K, Asano S. Leuk Res; 1993 Dec 21; 17(12):1079-82. PubMed ID: 7504152 [Abstract] [Full Text] [Related]
16. Regulation of megakaryocyte phenotype in human erythroleukemia cells. Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. J Clin Invest; 1990 Apr 21; 85(4):1072-84. PubMed ID: 2318965 [Abstract] [Full Text] [Related]
17. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Herrera R, Hubbell S, Decker S, Petruzzelli L. Exp Cell Res; 1998 Feb 01; 238(2):407-14. PubMed ID: 9473349 [Abstract] [Full Text] [Related]
18. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells. Jin UH, Ha KT, Kim KW, Chang YC, Lee YC, Ko JH, Kim CH. Biochim Biophys Acta; 2008 May 01; 1780(5):757-63. PubMed ID: 18339327 [Abstract] [Full Text] [Related]
19. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB. Exp Hematol; 2002 Sep 01; 30(9):990-1000. PubMed ID: 12225790 [Abstract] [Full Text] [Related]